NCT06676527 2025-12-05Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell CarcinomaJinling Hospital, ChinaRecruiting39 enrolled
NCT06659926 2025-07-08The Radium-select StudyThe Netherlands Cancer InstitutePhase NA Recruiting60 enrolled